High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhibitors

Tumors responding to immune checkpoint inhibitors (ICIs) have a higher level of immune infiltrates and/or an Interferon (IFN) signature indicative of a T-cell-inflamed phenotype. Melanoma and lung cancer demonstrate high response rates to ICIs and are commonly referred to as “hot tumors”. These are...

Descripción completa

Detalles Bibliográficos
Autor principal: Maleki Vareki, Saman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307306/
https://www.ncbi.nlm.nih.gov/pubmed/30587233
http://dx.doi.org/10.1186/s40425-018-0479-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307306/
https://www.ncbi.nlm.nih.gov/pubmed/30587233
http://dx.doi.org/10.1186/s40425-018-0479-7

Ejemplares similares